JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB243656

Anti-LATS1/WARTS antibody [EPR23057-116]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

Be the first to review this product! Submit a review

|

(17 Publications)

Rabbit Recombinant Monoclonal LATS1/WARTS antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples. Cited in 17 publications.

View Alternative Names

WARTS, LATS1, Serine/threonine-protein kinase LATS1, Large tumor suppressor homolog 1, WARTS protein kinase, h-warts, Warts, Serine/threonine-protein kinase LATS1, Large tumor suppressor homolog 1, WARTS protein kinase

5 Images
Flow Cytometry (Intracellular) - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)

Intracellular flow cytometric analysis of 4% paraformaldehyde fixed, 90% methanol permeabilized HeLa (human cervix adenocarcinoma epithelial cell) cells labelling LATS1/WARTS with ab243656 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.

Flow Cytometry (Intracellular) - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)

Intracellular flow cytometric analysis of 4% paraformaldehyde, fixed 90% methanol permeabilized NIH/3T3 (mouse embryonic fibroblast) cells labelling LATS1/WARTS with ab243656 at 1/500 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.

Western blot - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)
  • WB

Lab

Western blot - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)

Blocking and dilution buffer : 5% NFDM/TBST.

Exposure times.

Lane 1 : 81 seconds;

Lanes 2-3 : 3 minutes

The molecular weight observed is consistent with what has been described in the literature (PMID : 30293781).

Bands below 150KD are likely to be degraded LATS1 (PMID : 23573293).

Lysates should be made fresh and used in WB immediately to minimize protein degradation.

All lanes:

Western blot - Anti-LATS1/WARTS antibody [EPR23057-116] (ab243656) at 1/1000 dilution

Lane 1:

NIH/3T3 (mouse embryonic fibroblast) whole cell lysate at 10 µg

Lane 2:

HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 3:

PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 126 kDa

Observed band size: 150 kDa

false

Western blot - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)
  • WB

Lab

Western blot - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)

Western blot : Anti-LATS1 antibody [EPR23057-116] (ab243656) staining at 1/2000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab243656 was shown to bind specifically to LATS1. A band was observed at 127 kDa in wild-type THP-1 cell lysates with no signal observed at this size in LATS1 knockout cell line. To generate this image, wild-type and LATS1 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-LATS1/WARTS antibody [EPR23057-116] (ab243656) at 1/2000 dilution

Lane 1:

Wild-type THP-1 cell lysate at 20 µg

Lane 2:

Western blot - Human LATS1 (WARTS) knockout THP-1 cell line (<a href='/en-us/products/cell-lines/human-lats1-warts-knockout-thp-1-cell-line-ab277862'>ab277862</a>)

Lane 2:

LATS1 knockout THP-1 cell lysate at 20 µg

Lane 3:

HT-29 cell lysate at 20 µg

Lane 4:

PC-3 cell lysate at 20 µg

Lane 5:

HeLa cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Predicted band size: 126 kDa

Observed band size: 127 kDa

false

Western blot - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)
  • WB

Unknown

Western blot - Anti-LATS1/WARTS antibody [EPR23057-116] (AB243656)

Blocking and dilution buffer : 5% NFDM/TBST.

Exposure time : 3 minutes.

Samples loaded are extracts of E.coil expressing either LATS1 or LATS2.

All lanes:

Western blot - Anti-LATS1/WARTS antibody [EPR23057-116] (ab243656) at 1/1000 dilution

Lane 1:

His-tagged human LATS1 recombinant protein at 10 ng

Lane 2:

His-tagged human LATS2 recombinant protein at 10 ng

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution

Predicted band size: 126 kDa

false

Exposure time: 3min

  • Carrier free

    Anti-LATS1/WARTS antibody [EPR23057-116] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR23057-116

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

Flow Cyt (Intra), WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/500", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/500", "FlowCytIntra-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LATS1/WARTS also known as Large Tumor Suppressor 1 is a serine/threonine protein kinase with a molecular mass of approximately 125 kDa. Its expression is found in various tissue types including skin lung and liver. Mechanically LATS1/WARTS plays a critical role in regulating the cell cycle and maintaining genomic stability. This kinase is an essential part of the Hippo signaling pathway and contributes to controlling the size of organs by inhibiting cell proliferation and promoting apoptosis.
Biological function summary

LATS1/WARTS functions as an important regulator of cellular growth and differentiation. It is part of the Hippo signaling complex which includes proteins like MST1/2 and YAP/TAZ. This complex helps maintain proper tissue homeostasis by modulating gene expression in response to cellular density and mechanical cues. In doing so LATS1/WARTS phosphorylates and inactivates downstream effectors YAP and TAZ preventing them from translocating to the nucleus where they could promote transcription of growth-promoting genes.

Pathways

Scientists have found LATS1/WARTS to be integral to both the Hippo signaling pathway and the cell cycle regulation pathway. Within these pathways LATS1/WARTS interacts closely with proteins such as MOB1 and YAP mediating cellular responses to growth inhibitory signals. By controlling these interactions LATS1/WARTS helps coordinate cell proliferation and apoptosis which is critical for proper developmental processes and prevention of tumor growth.

Dysregulation of LATS1/WARTS function is associated with the development of cancers particularly in the liver and breast. Research also links LATS1/WARTS to neurodegenerative conditions by implicating its role in apoptosis and cell survival. When its kinase activity is compromised the regulatory balance maintained by the Hippo pathway is disrupted potentially leading to unchecked cell proliferation. Connections with proteins such as YAP and TAZ further illustrate its involvement in these pathological conditions showing its importance in maintaining cellular integrity and function.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed : 10518011, PubMed : 10831611, PubMed : 18158288, PubMed : 26437443, PubMed : 28068668). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed : 18158288, PubMed : 26437443, PubMed : 28068668). Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed : 18158288, PubMed : 26437443, PubMed : 28068668). Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint (PubMed : 15122335, PubMed : 19927127). Negatively regulates G2/M transition by down-regulating CDK1 kinase activity (PubMed : 9988268). Involved in the control of p53 expression (PubMed : 15122335). Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1 (PubMed : 15220930). May also play a role in endocrine function. Plays a role in mammary gland epithelial cell differentiation, both through the Hippo signaling pathway and the intracellular estrogen receptor signaling pathway by promoting the degradation of ESR1 (PubMed : 28068668). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed : 39173637).
See full target information LATS1

Additional targets

,

Publications (17)

Recent publications for all applications. Explore the full list and refine your search

BMC cancer 25:408 PubMed40050771

2025

SIRT7 affects the proliferation and apoptosis of papillary thyroid cancer cells by desuccinylation of LATS1.

Applications

Unspecified application

Species

Unspecified reactive species

Qinghua Li,Gang Pu

Neoplasia (New York, N.Y.) 60:101102 PubMed39674114

2024

USP20 mediates malignant phenotypic changes in bladder cancer through direct interactions with YAP1.

Applications

Unspecified application

Species

Unspecified reactive species

Wensun Chen,Siqi Wu,Yifan Chen,Weijian Li,Yiqing Cao,Yingchun Liang,Xiyu Dai,Xinan Chen,Yilin Chen,Tian Chen,Shenghua Liu,Chen Yang,Haowen Jiang

Anti-cancer drugs 35:902-911 PubMed39012720

2024

Interference with PLA2G16 promotes cell cycle arrest and apoptosis and inhibits the reprogramming of glucose metabolism in multiple myeloma cells by modulating the Hippo/YAP signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Hongyan Li,Yi Zhang,Xiaoyu Mou,Bo Huang,Xiaoqiang Fan

iScience 27:109667 PubMed38966570

2024

upregulated by promotes ferroptosis via inhibiting axis in sepsis-induced acute lung injury.

Applications

Unspecified application

Species

Unspecified reactive species

Hong Lv,Jing Yu,Xingjia Qian,Jun Shu,Qiuhong Qian,Luhong Shen,Dongfang Shi,Zhengzheng Tao,Guiqin Fan,Bufeng Zhuang,Bing Lu

Helicobacter 29:e13109 PubMed38951739

2024

Integrin-Linked Kinase in the Development of Gastric Tumors Induced by Helicobacter pylori: Regulation and Prevention Potential.

Applications

Unspecified application

Species

Unspecified reactive species

Boqing Li,Jing He,Ruiqing Zhang,Sisi Liu,Xiaolin Zhang,Zhiqin Li,Chunlei Ma,Wenke Wang,Yingzi Cui,Ying Zhang

Discover oncology 15:73 PubMed38478152

2024

GALNT2 targeted by miR-139-5p promotes proliferation of clear cell renal cell carcinoma via inhibition of LATS2 activation.

Applications

Unspecified application

Species

Unspecified reactive species

Haisheng Yi,Lingyun Liu,Jingshun Zhang,Kaimin Guo,Yin Cao,Penghao Sun,Hongliang Wang

Oncology letters 26:331 PubMed37415630

2023

Long non‑coding RNA PTCSC3 suppresses triple‑negative breast cancer by downregulating long non‑coding RNA MIR100HG.

Applications

Unspecified application

Species

Unspecified reactive species

Guojun Zhang,Lei Gao,Junliang Zhang,Rui Wang,Xiangdong Wei

MedComm 4:e293 PubMed37287755

2023

Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization.

Applications

Unspecified application

Species

Unspecified reactive species

Lu Liang,Wenyan Xu,Ao Shen,Xiaomei Fu,Huiyu Cen,Siran Wang,Zhongxiao Lin,Lingmin Zhang,Fangyu Lin,Xin Zhang,Na Zhou,Jishuo Chang,Zhe-Sheng Chen,Chuwen Li,Xiyong Yu

Cell proliferation 55:e13221 PubMed35355356

2022

FGF6 promotes cardiac repair after myocardial infarction by inhibiting the Hippo pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Zhicheng Hu,Peng Chen,Linlin Wang,Yu Zhu,Gen Chen,Yunjie Chen,Zhenyu Hu,Lin Mei,Weijing You,Weitao Cong,Litai Jin,Xu Wang,Yang Wang,Xueqiang Guan

Cell death discovery 8:111 PubMed35279674

2022

Clock-modified mesenchymal stromal cells therapy rescues molecular circadian oscillation and age-related bone loss via miR142-3p/Bmal1/YAP signaling axis.

Applications

Unspecified application

Species

Unspecified reactive species

Sa Cha,Jiangyue Wang,Sueng Min Lee,Zhen Tan,Qing Zhao,Ding Bai
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com